Benzodiazepine receptor deficiency and tinnitus

International Tinnitus Journal

Volumn 6, Issue 2, 2000, Pages 98-111

  Shulman, A ^a   Strashun, A M ^a   Seibyl, J P ^a   Daftary, A ^a   Goldstein, B ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

123I Iomazenil; Affect; Benzodiazepine receptor; Final common pathway; Medial temporal lobe system; Sensory; SPECT imaging of brain; Stress

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE RECEPTOR; IODINE 123; IOMAZENIL; RADIOLIGAND;

ADULT; AGED; ANXIETY; BINDING SITE; CLINICAL ARTICLE; CONFERENCE PAPER; CORRELATION FUNCTION; DEPRESSION; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GABAERGIC SYSTEM; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR DENSITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS; SYMPTOM; TEMPORAL LOBE; TINNITUS;

ADULT; AGED; BRAIN; FEMALE; FLUMAZENIL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; QUESTIONNAIRES; RECEPTORS, GABA-A; TINNITUS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034495679     PISSN: 09465448     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (76)

1. Neurospect cerebral blood flow studies in patients with a central type tinnitus: Preliminary study
2. SPECT imaging of brain and tinnitus - Neurotologic/neurologic implications
3. Neurotransmitter, receptor and biochemical changes in monkey cortical epileptic foci
4. In vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci
5. "Central" and "peripheral" benzodiazepine receptors; opposite changes in human epileptogenic tissue
6. Change in benzodiazepine receptors in Alzheimer type dementia
7. Quantitative autoradiography of neurotransmitter receptors in Huntington disease
8. Benzodiazepine and GABA receptors in early Huntington's disease
9. Neurotransmitter receptor alterations in Huntington's disease: Autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes
10. Benzodiazepine receptors increase in postmortem brain of chronic schizophrenia
11. Increased GABA receptor binding in superficial layers of cingulate cortex in schizophrenics
12. Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: Is selective loss of glutamatergic neurons associated with major psychoses?
13. Stress, sex and the structural and functional plasticity of the hippocampus
14. Effects of antidepressants and a benzodiazepine on the dendritic structure of CA3 pyramidal neurons after chronic stress
15. Re-examination of the glucocorticoid hypothesis of stress and aging
16. Tinnitology, tinnitogenesis, nuclear medicine, and tinnitus patients
17. Pharmacokinetics of the SPECT benzodiazepine receptor radioligand (I-123) Iomazenil in human and nonhuman primates
18. Human biodistribution and dosimetry of the SPECT benzodiazepine receptor radioligand iodine 123-Iomazenil
19. SPECT measurements of benzodiazepine receptors in human brain with Iodine 123-Iomazenil: Kinetic and equilibrium paradigms
20. Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans
21. Medical audiologic tinnitus patient protocol
22. SPECT imaging of brain and tinnitus - Neurotologic/neurologic implications
23. Appearance at pathophysiologic loci in central type tinnitus: A Tc99mHMPAO study
24. A final common pathway for tinnitus - The medial temporal lobe system
25. Final common pathway for tinnitus - Implications for treatment
26. Benzodiazepines in the treatment of tinnitus
27. Use of alprazolam for relief of tinnitus - A double blind study
28. Benzodiazepines in the treatment of tinnitus
29. Medical significance of tinnitus
30. Uptake of corticosterone by the rat brain and its concentration in certain limbic structures
31. Loss of glucocorticoid fast feedback in depression
32. Stress model for tinnitus
33. Subtypes of gamma-aminobutyric acid A receptors; Classification on the basis of subunit structure and receptor function
34. Neuroprotective drug therapy: A medical and pharmacological treatment for tinnitus control
35. Neurontin (gabapentin)
36. The lateral amygdaloid nucleus
37. Descending auditory system/cerebellum/tinnitus
38. The role of adrenocorticoids as modulators of immune function in health and disease
39. Adrenal steroid receptors and actions in the nervous system
40. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Involvement of glucocorticoid secretion and excitatory amino acid receptors
41. Reduced benzodiazepine receptor binding in panic disorders measured by Iomazenil SPECT
42. A phase 3 clinical trial of I-123 Iomazenil, a new central-type benzodiazepine receptor imaging agent: 2. Report on clinical usefulness in diagnosis of degenerative neurological diseases and mental disorders
43. Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABA-A receptor function
44. Chronic diazepam treatment produces specific changes in GABA stimulated chloride influx
45. Disabling tinnitus: Association with affective disorder
46. Functional selection of adaptive auditory space map by GABA A-mediated inhibition
47. Antagonism between anesthetic steroid hormone and pentamethyalene tetrazole (metrezal)
48. Non-genomic effects of steroids in neural activity
49. Chronic neurosteroid treatment produces functional heterologous uncoupling at the gamma-aminobutyric acid-A/benzodiazepine receptor complex in mammalian cortical neurons
50. Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain
51. Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma
52. GABA-A receptor alpha 4 subunit suppression prevents with-drawal properties of an endogenous steroid
53. Use-dependent regulation of GABA-A receptors
54. Prolonged GABA responses in dentate granule cells in slices isolated from patients with temporal lobe sclerosis
55. Gamma-aminobutyric acid, receptor regulation in culture: Altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines
56. Chronic GABA exposure down-regulates GABA benzodiazepine receptor-ionophore complex in cultured cerebral cortical neurons
57. Development of tolerance to anti-convulsant effect of GABAmimetic drugs in genetically epilepsy prone gerbils
58. Regional GABA benzodiazepine receptor/chloride channel coupling after acute and chronic benzodiazepine treatment
59. Biochemical and electrophysiological mechanisms underlying benzodiazepine tolerance and dependence
60. Neurotransmitters have developmental signs
61. GABA receptor subunit polypeptides increase in parallel but exhibit distinct distributions in the developing rat cerebellum
62. Multiplicity of GABA-A benzodiazepine receptors
63. Binding of benzodiazepines and some major metabolites at their sites in normal human frontal cortex in vitro
64. Multiple benzodiazepine receptor localization by light microscopic radiohistochemistry
65. Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans
66. Benzodiazepine receptor binding of triazolobenzodiazepine in vivo: Increased receptor number with low-dose alprazolam
67. Low-dose alprazolam augments motor activity in mice
68. Benzodiazepine receptor binding in vivo